Boxlight Corp (BOXL): Nasdaq/NYSE listing notice — Boxlight receives Nasdaq delisting notice for failing equity and market value requirements

Boxlight Corp

Stockholders' equity of ($12.896M) and net losses of $28.335M (2024) and $39.156M (2023) reported.
Market value of listed securities was $2.83M as of April 4, 2025, far below the $35M minimum.
Company has 45 days to submit a plan to regain compliance; if accepted, up to 180 days to comply.
Delisting could materially harm market price, liquidity, and ability to raise equity capital.
Notice has no immediate effect; Boxlight intends to evaluate options and submit a plan.

item 3.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.98

Boxlight Corp received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: stockholders equity
Rules: 5550(b)

Exact text from the filing

April 7, 2025, Boxlight Corporation, a Nevada corporation (the “Company”), received a letter (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) notifying the Company that it did not satisfy the continued listing requirements under Nasdaq Listing Rule 5550(b) for the Nasdaq Capital Market. Rule 5550(b) requires that a listed company must satisfy one of the following three standards: (1) stockholders’ equity of at least $2.5 million; (2) market value of listed securities of at least $35 million; or (3) net income from continuing operations of $500,000

View on SEC.gov

Browse all listing & compliance notices →

Boxlight Corp filing history →

Source: SEC EDGAR

accession 0001104659-25-032642

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.